Projects per year
Personal profile
Education
- 2009 Ph.D., Graduate Institute of Clinical Medicine, Taipei Medical University
- 1985-1992 M.D., School of Medicine, National Taiwan University
Experience
- 2023.04- Vice Superintendent, Taipei Medical University Hospital
- 2021.08- Chairman, Department of Quality Management, Taipei Medical University Hospital
- 2019.01-2023.04 Vice Superintendent, Taipei Medical University Hospital
- 2017.08- Professor, International Ph.D. Program for Cell Therapy and Regeneration Medicine, Taipei Medical University
- 2020.11-2021.07 Director, Department of Nuclear Medicine, Taipei Medical University Hospital
- 2016.06-2017.07 Deputy Director, School of Medicine, College of Medicine, Taipei Medical University
- 2015.08- Professor, Department of Surgery, School of Medicine, College of Medicine, Taipei Medical University
- 2015.08- Professor, Master Program in Clinical Pharmacogenomics and Pharmacoproteomics, Taipei Medical University
- 2015 Vice Chairman, Department of Surgery, Taipei Medical University Hospital
- 2015.08-2016.07 Chairman, Department of Quality Management, Taipei Medical University Hospital
- 2014.08- Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University
- 2014.02- Ph.D. Program for Cancer Molecular Biology and Drug Discovery, Taipei Medical university
- 2012.08-2015.07 Associate Professor, Department of Surgery, School of Medicine, College of Medicine, Taipei Medical University
- 2009.08-2012.07 Assistant Professor, Department of Surgery, School of Medicine, College of Medicine, Taipei Medical University
- 2008 Chief, Division of General Surgery, Taipei Medical University Hospital
- 2006 Attending Doctor, General Surgery, Taipei Medical University Hospital
- 2006.02-2009.07 Instructor, Department of Surgery, School of Medicine, College of Medicine, Taipei Medical University
- 2005.12-2006.05 Director, Division of Rectal Surgery, Min-Sheng Hospital
- 2004.07-2005.11 Director, Division of General Surgery, En Chu Kong Hospital
- 2003.07-2004.06 Director, Division of Rectal Surgery, En Chu Kong Hospital
- 1997.07-2006.06 Attending Physician, Department of Surgery, En Chu Kong Hospital
- 1992.07-1997.06 Resident Physician, Department of Surgery, National Taiwan University Hospital
Awards
- 2015 Faculty Award of Taipei Medical University
- 2015 Distinguished Teaching Award of College of Medicine, Taipei Medical University
- 2013 Best Advisor Award of College of Medicine, Taipei Medical University
- 2011 The excellent thesis of the year 2010 by international college of surgeons
Research Interests
- Cancer molecular biology
- Signal transduction
- ER stress and metastasis
- Colorectal Surgery
Related Link
Fingerprint
- 1 Similar Profiles
Network
-
Investigate the Regulatory Mechanism and Therapeutic Roles of Msn in Colorectal Cancer (Continuation Project)
8/1/22 → 7/31/23
Project: A - Government Institution › b - Ministry of Science and Technology
-
研究MSN在大腸直腸癌中對病程進展的調控機制和其治療角色
8/1/21 → 7/31/22
Project: A - Government Institution › b - Ministry of Science and Technology
-
探討PCTK1激?蛋白在大腸直腸癌發展的角色及其調控機制(延續計畫)(3/3)
8/1/20 → 7/1/21
Project: A - Government Institution › b - Ministry of Science and Technology
-
To Study the Role of Pctk1 in the Progression of Colorectal Cancer and Molecular Mechanism (Continuation Project)(2/3)
8/1/19 → 7/31/20
Project: A - Government Institution › b - Ministry of Science and Technology
-
To Study the Role of Pctk1 in the Progression of Colorectal Cancer and Molecular Mechanism (Continuation Project)(1/3)
8/1/18 → 7/31/19
Project: A - Government Institution › b - Ministry of Science and Technology
-
In silico analysis to identify miR-1271-5p/PLCB4 (phospholipase C Beta 4) axis mediated oxaliplatin resistance in metastatic colorectal cancer
Lee, C-C., Lee, A-W., Wei, P-L., Liu, Y-S., Chang, Y-J. & Huang, C-Y., 2023, In: Scientific Reports. 13, 1Research output: Contribution to journal › Article › peer-review
-
Aldehyde Dehydrogenase 2 Family Member (ALDH2) Is a Therapeutic Index for Oxaliplatin Response on Colorectal Cancer Therapy with Dysfunction p53
Wang, W. L., Batzorig, U., Hung, C. S., Wei, P. L., Huang, C. Y. & Chang, Y. J., 2022, In: BioMed Research International. 2022, 1322788.Research output: Contribution to journal › Article › peer-review
Open Access2 Citations (Scopus) -
Cigarette Smoking Associated with Colorectal Cancer Survival: A Nationwide, Population-Based Cohort Study
Huang, Y. M., Wei, P. L., Ho, C. H. & Yeh, C. C., Feb 2 2022, In: Journal of Clinical Medicine. 11, 4, 913.Research output: Contribution to journal › Article › peer-review
Open Access3 Citations (Scopus) -
Clinical assessment for non-reversal stoma and stoma re-creation after reversal surgery for rectal cancer patients after sphincter-saving operation
Kuo, C. Y., Lin, Y. K., Wei, P. L., Chi-Yong Ngu, J., Lee, K. D., Chen, C. L., Huang, Y., Chen, C. C. & Kuo, L. J., 2022, (Accepted/In press) In: Asian Journal of Surgery.Research output: Contribution to journal › Article › peer-review
Open Access -
Clinical Safety and Effectiveness of Robotic-Assisted Surgery in Patients with Rectal Cancer: Real-World Experience over 8 Years of Multiple Institutions with High-Volume Robotic-Assisted Surgery
Huang, C. W., Wei, P. L., Chen, C. C., Kuo, L. J. & Wang, J. Y., Sept 2022, In: Cancers. 14, 17, 4175.Research output: Contribution to journal › Article › peer-review
Open Access1 Citation (Scopus)
Datasets
-
Additional file 2: Figure S1. of Ovatodiolide suppresses colon tumorigenesis and prevents polarization of M2 tumor-associated macrophages through YAP oncogenic pathways
Huynh, T. (Contributor), Tzeng, Y. (Contributor), Yen, Y. (Creator), Yang, C. (Contributor), Wu, A. T. (Creator), Meng, T. (Contributor), Whang-Peng, J. (Creator), Wei, P. (Contributor), Hsiao, M. (Creator) & Huang, Y. (Contributor), Figshare, 2017
DOI: 10.6084/m9.figshare.c.3704533_d1.v1, https://doi.org/10.6084%2Fm9.figshare.c.3704533_d1.v1
Dataset
-
Additional file 3 of EGFL6 promotes colorectal cancer cell growth and mobility and the anti‐cancer property of anti-EGFL6 antibody
HuangFu, W. (Creator), Sung, T. (Creator), Lee, Y. (Contributor), Pan, S. (Creator), Cheng, Y. (Creator), Chang, F. (Creator), Wei, P. (Contributor), Huang, C. (Contributor), Huang, H. (Contributor) & Cheng, C. (Creator), Figshare, 2021
DOI: 10.6084/m9.figshare.14228284.v1, https://doi.org/10.6084%2Fm9.figshare.14228284.v1
Dataset
-
Additional file 2 of EGFL6 promotes colorectal cancer cell growth and mobility and the anti‐cancer property of anti-EGFL6 antibody
Huang, H. (Contributor), HuangFu, W. (Creator), Cheng, Y. (Creator), Cheng, C. (Creator), Chang, F. (Creator), Sung, T. (Creator), Pan, S. (Creator), Lee, Y. (Contributor), Wei, P. (Contributor) & Huang, C. (Contributor), Figshare, 2021
DOI: 10.6084/m9.figshare.14228281.v1, https://doi.org/10.6084%2Fm9.figshare.14228281.v1
Dataset
-
Additional file 1: Figure S2. of Ovatodiolide suppresses colon tumorigenesis and prevents polarization of M2 tumor-associated macrophages through YAP oncogenic pathways
Whang-Peng, J. (Creator), Yen, Y. (Creator), Huang, Y. (Contributor), Yang, C. (Contributor), Tzeng, Y. (Contributor), Meng, T. (Contributor), Wu, A. T. (Creator), Wei, P. (Contributor), Huynh, T. (Contributor) & Hsiao, M. (Creator), Figshare, 2017
DOI: 10.6084/m9.figshare.c.3704533_d2.v1, https://doi.org/10.6084%2Fm9.figshare.c.3704533_d2.v1
Dataset
-
Ovatodiolide suppresses colon tumorigenesis and prevents polarization of M2 tumor-associated macrophages through YAP oncogenic pathways
Huang, Y. (Contributor), Yang, C. (Contributor), Wei, P. (Contributor), Huynh, T. (Contributor), Whang-Peng, J. (Creator), Meng, T. (Contributor), Hsiao, M. (Creator), Tzeng, Y. (Contributor), Wu, A. T. (Creator) & Yen, Y. (Creator), Figshare, 2017
DOI: 10.6084/m9.figshare.c.3704533.v1, https://doi.org/10.6084%2Fm9.figshare.c.3704533.v1
Dataset